دورية أكاديمية

The 'real-world' effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study

التفاصيل البيبلوغرافية
العنوان: The 'real-world' effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study
المؤلفون: Simona Siracká, Lenka Tinková, Luděk Hochmuth, Helena Leščišinová, Martin Hrubiško, Katarína Dostálová, Miloš Jeseňák
المصدر: Advances in Dermatology and Allergology, Vol 40, Iss 1, Pp 134-141 (2022)
بيانات النشر: Termedia Publishing House
سنة النشر: 2022
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: asthma exacerbations, global evaluation of treatment effectiveness, lung function, omalizumab, real-world evidence, severe allergic asthma, Dermatology, RL1-803, Internal medicine, RC31-1245
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 1642-395X
2299-0046
العلاقة: https://www.termedia.pl/The-real-world-effectiveness-and-safety-of-omalizumab-in-patients-with-uncontrolled-persistent-allergic-asthma-in-Slovakia-a-subgroup-analysis-of-the-eXpeRience-study,7,47099,1,1.htmlTest; https://doaj.org/toc/1642-395XTest; https://doaj.org/toc/2299-0046Test; https://doaj.org/article/fea64ceca78440eea310f47e9df9b721Test
DOI: 10.5114/ada.2022.116532
الإتاحة: https://doi.org/10.5114/ada.2022.116532Test
https://doaj.org/article/fea64ceca78440eea310f47e9df9b721Test
رقم الانضمام: edsbas.C28ED9B1
قاعدة البيانات: BASE
الوصف
تدمد:1642395X
22990046
DOI:10.5114/ada.2022.116532